|
NEWLY AVAILABLE, NEWLY APPROVED
Night Splint
|
AliMed, Inc., has developed the D2 Night
Splint to help athletes with plantar
fasciitis return to their sport more
quickly.
The D2 Dorsal Night Splint provides
a progressive stretch force to the plantar
fascia, Achilles tendon, and calf musculature.
It delivers stretch, not through a fixed
shell, but with an adjustable dynamic
cord that provides a constant low-load
force throughout the night. As tolerance
improves, the stretch can be increased.
This leads to better patient compliance
and quicker healing.
AliMed notes that patients can wear
the D2 Night Splint the entire night
and can easily control the stretch of
the splint, allowing all-night comfort
as they continue the healing process.
The bottom of the splint is plastic-free,
and the hinged ankle allows for a more
natural gait.
For more information about the D2 Night Splint or for a free copy of AliMed’s
Splints and Braces catalog, contact AliMed, Inc.,
AliMed, Inc.
297 High Street
Dedham, MA 02026
phone (800) 225-2610
www.alimed.com |
Advanced Energy Surgical
Device
|
Salient Surgical Technologies, Inc., has introduced the Aquamantys™ Malleable
Bipolar Sealer with Light (MBS). The MBS employs Transcollation™ technology
to significantly reduce bleeding in hard-to-reach anatomy during joint replacement
surgery. The company notes that reducing blood loss improves visualization for
the surgeon and may result in improved clinical outcomes for the patient and
lower costs to the hospital.
The innovation of the MBS is a malleable shaft that allows surgeons to shape
the device to help fit the particular surgical situation. The shaft also features
a lighted tip to improve visibility. The MBS is used with the same Aquamantys
System Generator as the Company’s standard 2.3 and 6.0 Bipolar Sealer devices.
Contact Salient Surgical Technologies, Inc., for more information at
Salient Surgical Technologies, Inc.
One Washington Center, Suite 400
phone (800) 354-2808
www.salientsurgical.com |
Integrated and
Wireless Mobile Detector Technology
|
Siemens Healthcare has received FDA 510(k) market clearance for the Ysio™,
a new-generation digital radiography system with a wireless detector (wi-D™)
for maximum positioning flexibility.
Offering one digital radiography (DR) solution for virtually all clinical demands
of the growing digital radiography market, the Ysio is available in a variety
of configurations based on customers’ imaging needs: as a wall stand with
an integrated detector, as a wall stand and table system with a wireless detector,
or as a mixed detector solution for high throughput and flexibility. Ysio serves
as an integrated command center where users can control their workflow from registration
to image-data management with features like more than 500 automated system positions;
power-assisted movements; a unique table design, together with the wi-D; and
a color touchscreen panel for convenient system utilization.
For more information, contact
Siemens Medical Solutions USA, Inc.
51 Valley Stream Parkway
Malvern, PA 19355
www.siemens.com/healthcare |
Endoscopic Cubital
Tunnel Release System
|
Integra LifeSciences Holdings Corporation announced the introduction of the EndoRelease™ Endoscopic Cubital Tunnel Release System. Designed for the surgical treatment
of cubital tunnel syndrome, the EndoRelease™ System offers a new, minimally
invasive approach through a series of innovative instruments designed for safely
releasing fascia surrounding the ulnar nerve. The company notes that potential
benefits offered by the EndoRelease System include a smaller incision, an efficient
and reliable surgical technique, and more rapid patient recovery.
For more information, contact
Integra-LS
311 Enterprise Drive
Plainsboro, NJ 08536
phone (609) 275-0500
www.Integra-LS.com
|
Acellular Xenograft
Matrix
|
Wright Medical Group, Inc., announced the launch of BIOTAPE XM™ Reinforcement
Matrix, a sterile, acellular xenograft matrix for reinforcement of soft-tissue
repairs in foot and ankle surgical procedures.
The company notes that human biomechanical tests and animal studies with BIOTAPE
XM™ Matrix reveal encouraging data for patients in need of surgical repair
of injured tendons. When used to reinforce the repair of a tendon, BIOTAPE XM™ Matrix
increases the strength of the initial repair by 70% on average when compared
with suture repair alone. In addition, the results of animal studies indicate
that the implant is well-tolerated by the host, allowing fibroblast repopulation,
revascularization, and bio-integration with host tissue.
For more information, contact
Wright Medical Group, Inc.
5677 Airline Road
Arlington, TN 38002
phone (901) 867-9971
www.wmt.com
|
|
